期刊文献+

左卡尼汀佐治冠心病合并室性心律失常的疗效观察 被引量:1

Clinical observation on L-carnitine in treatment of coronary heart disease patients complicated with ventricular arrhythmias
暂未订购
导出
摘要 目的观察左卡尼汀治疗冠心病合并室性心律失常的临床疗效。方法入选65例老年冠心病合并室性心律失常患者并随机分为A组(n=35)、B组(n=31),B组予常规心血管药物,A组在此基础上加用左卡尼汀,疗程均为2周,对比两组治疗后冠心病与心律失常治疗效果。结果①A组心绞痛治疗显效率(54.3%)与总体有效率(91.4%)均高于B组(29.0%、77.4%),显效率差异具有统计学意义(χ2=4.292 P=0.038)。②A组心律失常显效比例(48.6%)与总体有效率(88.6%)均高于对照组(29.0%、71.0%),但差异不均具有统计学意义(χ2=2.629 P=0.105;χ2=3.221 P=0.073)。结论外源性左卡尼汀佐治冠心病合并室性心律失常能减少心绞痛与心律失常的发生几率,提高生存质量。 Objective To observe clinical efficacy of L-carnitine in treatment of coronary heart disease patients complicated with ventricular arrhythmias.Methods 65 admitted cased were randomly divided into group A (n=35) & group B (n=31), patients in group B received conventional cardiovascular drugs,based orl which group A was added with intravenous injection of lg L-carni- tine,2 weeks for 1 treatment course,and efficacy were noted and compared of two groups.Results (1)Markedly effective rate (54.3% vs.29.0%)and overall effective rate(91.4% vs.77.4%) on angina pectoris of group A were both higher than group B, and the former was statistically significant (X2=4.292 P=0.038).(2)Markedly effective rate (48.6%vs.29.0%)and overall effective rate (88.6%vs. 71.0%)on improvement of arrhythmia of group A were both higher than group B either, but there were no statistical differences (X2=2.629 P=O.105 ;X2=3.221 P=0.073).Conclusion Exogenous supplement of L-carnitine on coronary heart disease patients complicatedw with ventricular arrhythmia can reduce the incidence of angina
出处 《中国卫生产业》 2014年第13期38-39,共2页 China Health Industry
关键词 左卡尼汀 冠心病 心律失常 疗效 L-camitine Coronary heart disease Arrhythmia Efficacy
  • 相关文献

参考文献7

二级参考文献49

  • 1蒋文平.胺碘酮抗心律失常治疗应用指南[J].中华心血管病杂志,2004,32(12):1065-1071. 被引量:143
  • 2孙彩霞,高春霖,薛玉良,冯雪辛,张永强,顾书华.左旋卡尼汀对大鼠心脏缺血-再灌注损伤能量代谢的影响[J].天津医药,2005,33(12):783-785. 被引量:15
  • 3蒋雄刚,李平,张凯伦.左旋卡尼汀对离体心肌缺血再灌注损伤的保护作用[J].中华实验外科杂志,2006,23(9):1038-1040. 被引量:5
  • 4周烨,徐东杰,陈椿,杨兵,陈明龙,单其俊,曹克将,邹建刚.美托洛尔注射剂治疗快速房性心律失常的临床研究[J].中国心脏起搏与心电生理杂志,2007,21(2):128-131. 被引量:12
  • 5Calvani M, Reda E, Arrigoni martelli E, Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions [J]. J Basic Res Cardiol, 2000, 95 (2): 75--83.
  • 6Yamada KA, Kanter EM, Newatia A. Long-chain acylcarnitine induces Ca^2+ efflux from the sarcoplasmic reticulum [J]. J Cardiovasc Pharmacol, 2000, 36 (1): 14--21.
  • 7Nemoto S, Aoki M, Dehua C, et al. Effects of carnitine on cardiac function after cardioplegic ischemia in neonatal rabbit hearts [J]. J Ann Thorac Surg, 2001, 71 (1): 254--259.
  • 8Borutaite V, Brown GC. Mitochondria in apoptosis of ischemic heart [J]. J FEBSLett, 2003, 541 (1--3): 1--5.
  • 9Paul DF,Pepine CJ. The role of carnitine in myocardial dysfunction[J]. J AmJ KidneyDis,2003,41(4 supp14):S35--S43.
  • 10Evans A. Dialysis-related carnitine disorder and levocarnitine pharmacology. Am J Kidney Dis, 2003,41 (4 Suppl 4 ) : S 13-26.

共引文献80

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部